MyChoice® is the first and only FDA-approved tumor test that determines HRD status using BRCA status and Genomic Instability Status.
詳しくは
The BRACAnalysis ® test assesses a person’s risk of developing hereditary breast or ovarian cancer based on the detection of mutations in the BRCA1 and BRCA2 genes.
Please try changing the search criteria, or reset filters